Compare BRTX & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRTX | AMST |
|---|---|---|
| Founded | 1997 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1M | 3.7M |
| IPO Year | 2015 | 2020 |
| Metric | BRTX | AMST |
|---|---|---|
| Price | $1.52 | $0.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 22.6K | ★ 28.4K |
| Earning Date | 11-24-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.83 |
| EPS | ★ N/A | N/A |
| Revenue | $81,000.00 | ★ $364,777.00 |
| Revenue This Year | N/A | $19,089.81 |
| Revenue Next Year | $383.87 | $22.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 230.24 |
| 52 Week Low | $0.14 | $0.46 |
| 52 Week High | $28.99 | $2.90 |
| Indicator | BRTX | AMST |
|---|---|---|
| Relative Strength Index (RSI) | 41.96 | 17.53 |
| Support Level | $1.32 | N/A |
| Resistance Level | $2.93 | $1.11 |
| Average True Range (ATR) | 0.14 | 0.05 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 53.07 | 11.44 |
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.
Amesite Inc is a technology company focused on building and commercializing AI (artificial intelligence)-powered solutions for the enterprise and for professionals, with particular emphasis on the post-acute healthcare market. It operates through two product lines: NurseMagic and LynkMagic. NurseMagic solutions include a B2B (business-to-business) enterprise application and a B2C (business-to-consumer) solution for individual healthcare professionals. LynkMagic provides enterprise AI solutions for healthcare and related organizations. Its products support documentation, workflow, compliance, oversight, and are designed to improve operational quality and efficiency. It has one single operating and reporting segment, B2C and B2B AI-driven solutions.